195 related articles for article (PubMed ID: 8038354)
1. Rapid healing of gastric ulcers with lansoprazole.
Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
[TBL] [Abstract][Full Text] [Related]
2. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
3. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
[TBL] [Abstract][Full Text] [Related]
4. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
6. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
Michel P; Lemaire M; Colin R; Bommelaer G; Rambaud JC; Dupas JL; Bigard MA; Verwaerd JC
Aliment Pharmacol Ther; 1994 Feb; 8(1):119-22. PubMed ID: 8186337
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse.
Bardhan KD; Crowe J; Thompson RP; Trewby PN; Keeling PN; Weir D; Crouch SL
Aliment Pharmacol Ther; 1999 Jun; 13(6):827-32. PubMed ID: 10383514
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
10. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
12. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
Robinson M; Sahba B; Avner D; Jhala N; Greski-Rose PA; Jennings DE
Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group.
Bardhan KD; Hawkey CJ; Long RG; Morgan AG; Wormsley KG; Moules IK; Brocklebank D
Aliment Pharmacol Ther; 1995 Apr; 9(2):145-51. PubMed ID: 7605854
[TBL] [Abstract][Full Text] [Related]
14. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
15. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
[TBL] [Abstract][Full Text] [Related]
16. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Arnold R; Hennig U; Fuchs W
Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
[TBL] [Abstract][Full Text] [Related]
18. A trial of lansoprazole in refractory gastric ulcer.
van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
[TBL] [Abstract][Full Text] [Related]
19. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
Langtry HD; Wilde MI
Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
